Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luting Yu

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Advanced Healthcare Materials|April 2, 2025
Regenerating Family Protein 3α-Loaded Responsive Hydrogel Accelerates Infected Diabetic Wound HealingQingyun Wu, Shenglong Jiang, Jia Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2015
The association of DNA methyltransferase 1 gene polymorphisms with susceptibility to childhood acute lymphoblastic leukemiaYing Luo, Luting Yu, Tingting Yu, et al.
Medcomm|March 6, 2025
Cholesterol-27α-hydroxylase inhibitor nilvadipine can effectively treat cholestatic liver injury in adult offspring induced by prenatal dexamethasone exposureWen Hu, Jiayong Zhu, Qi Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 27, 2023
Tumor-suppressive effect of Reg3A in COAD is mediated by T cell activation in nude miceLuting Yu, Yihan Zhou, Shaozheng Sun, et al.
Experimental Cell Research|September 12, 2020
Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancerPei Du, Xiaonan Wang, Tianqi Yin, et al.
Biomaterials|August 13, 2022
Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategyRan Han, Luting Yu, Chenxuan Zhao, et al.
Toxicology and Applied Pharmacology|January 9, 2022
Corrigendum to "cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expression" [Published in toxicology and applied pharmacology 352 (2018) 77-86, DOI: 10.1016/j.taap.2018.05.029]Luting Yu, Jin Zhou, Guohui Zhang, et al.
Toxicology and Applied Pharmacology|May 27, 2018
cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expressionLuting Yu, Jin Zhou, Guohui Zhang, et al.
International Journal of Biological Macromolecules|March 28, 2026
Development of a hydrogel-based drug delivery system for wound infection management with enhanced recombinant Reg3A bioactivityLuting Yu, Guanghao Lin, Yuxuan Lin, et al.
Biosensors|April 25, 2025
Single-Cell Endoscopy for Multifunctional Live-Cell Molecular AnalysisHaoze Xue, Li Wang, Han Yao, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Advanced Healthcare Materials|April 2, 2025
Regenerating Family Protein 3α-Loaded Responsive Hydrogel Accelerates Infected Diabetic Wound HealingQingyun Wu, Shenglong Jiang, Jia Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 28, 2015
The association of DNA methyltransferase 1 gene polymorphisms with susceptibility to childhood acute lymphoblastic leukemiaYing Luo, Luting Yu, Tingting Yu, et al.
Medcomm|March 6, 2025
Cholesterol-27α-hydroxylase inhibitor nilvadipine can effectively treat cholestatic liver injury in adult offspring induced by prenatal dexamethasone exposureWen Hu, Jiayong Zhu, Qi Zhang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|November 27, 2023
Tumor-suppressive effect of Reg3A in COAD is mediated by T cell activation in nude miceLuting Yu, Yihan Zhou, Shaozheng Sun, et al.
Experimental Cell Research|September 12, 2020
Anti-tumor effect of single-chain antibody to Reg3a in colorectal cancerPei Du, Xiaonan Wang, Tianqi Yin, et al.
Biomaterials|August 13, 2022
Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategyRan Han, Luting Yu, Chenxuan Zhao, et al.
Toxicology and Applied Pharmacology|January 9, 2022
Corrigendum to "cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expression" [Published in toxicology and applied pharmacology 352 (2018) 77-86, DOI: 10.1016/j.taap.2018.05.029]Luting Yu, Jin Zhou, Guohui Zhang, et al.
Toxicology and Applied Pharmacology|May 27, 2018
cAMP/PKA/EGR1 signaling mediates the molecular mechanism of ethanol-induced inhibition of placental 11β-HSD2 expressionLuting Yu, Jin Zhou, Guohui Zhang, et al.
International Journal of Biological Macromolecules|March 28, 2026
Development of a hydrogel-based drug delivery system for wound infection management with enhanced recombinant Reg3A bioactivityLuting Yu, Guanghao Lin, Yuxuan Lin, et al.
Biosensors|April 25, 2025
Single-Cell Endoscopy for Multifunctional Live-Cell Molecular AnalysisHaoze Xue, Li Wang, Han Yao, et al.
Pageof 4